| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Syros Pharmaceuticals Inc (NASDAQ: SYRS)
SYRS Technical Analysis
5
| As on 11th Mar 2025 SYRS STOCK Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.07 & Strong Sell for SHORT-TERM with Stoploss of 2.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SYRSSTOCK Price
| Open | 0.15 | Change | Price | % |
| High | 0.30 | 1 Day | 0.05 | 55.56 |
| Low | 0.13 | 1 Week | 0.00 | 0.00 |
| Close | 0.14 | 1 Month | -0.06 | -30.00 |
| Volume | 693010424 | 1 Year | -3.84 | -96.48 |
| 52 Week High 7.84 | 52 Week Low 0.08 | ||||
NASDAQ USA Most Active Stocks
| SYRS | 0.14 | 55.56% |
| AMRS | 0.14 | 100.00% |
| BHAT | 0.04 | 33.33% |
| NVDA | 108.76 | 1.66% |
| CUTR | 0.11 | -15.38% |
| AWH | 0.18 | -10.00% |
| TSLA | 230.58 | 3.79% |
| LMDX | 0.02 | 0.00% |
| LCID | 2.09 | 0.48% |
| AAL | 11.46 | -8.32% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SYRS Daily Charts |
SYRS Intraday Charts |
Whats New @ Bazaartrend |
SYRS Free Analysis |
|
|
SYRS Important Levels Intraday
| RESISTANCE | 0.47 |
| RESISTANCE | 0.36 |
| RESISTANCE | 0.30 |
| RESISTANCE | 0.23 |
| SUPPORT | 0.05 |
| SUPPORT | -0.02 |
| SUPPORT | -0.08 |
| SUPPORT | -0.19 |
SYRS Forecast March 2025
| 4th UP Forecast | 2.12 |
| 3rd UP Forecast | 1.49 |
| 2nd UP Forecast | 1.09 |
| 1st UP Forecast | 0.7 |
| 1st DOWN Forecast | -0.42 |
| 2nd DOWN Forecast | -0.81 |
| 3rd DOWN Forecast | -1.21 |
| 4th DOWN Forecast | -1.84 |
SYRS Weekly Forecast
| 4th UP Forecast | 2.45 |
| 3rd UP Forecast | 1.71 |
| 2nd UP Forecast | 1.25 |
| 1st UP Forecast | 0.79 |
| 1st DOWN Forecast | -0.51 |
| 2nd DOWN Forecast | -0.97 |
| 3rd DOWN Forecast | -1.43 |
| 4th DOWN Forecast | -2.17 |
SYRS Forecast2025
| 4th UP Forecast | 15.75 |
| 3rd UP Forecast | 10.74 |
| 2nd UP Forecast | 7.65 |
| 1st UP Forecast | 4.55 |
| 1st DOWN Forecast | -4.27 |
| 2nd DOWN Forecast | -7.37 |
| 3rd DOWN Forecast | -10.46 |
| 4th DOWN Forecast | -15.47 |
Syros Pharmaceuticals Inc ( NASDAQ USA Symbol : SYRS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SYRS Business Profile
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Phase II clinical trial for genomically defined subset of patients with acute myeloid leukemia and phase III clinical trial for patents with myelodysplastic syndrome; SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors; and SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia. It has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts. Address: 35 CambridgePark Drive, Cambridge, MA, United States, 02140
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service